Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Welcome to the last day of tax-loss selling ...

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Jan 09, 2023 3:55pm

194 Views

Post# 35211928

RE:RE:RE:RE:RE:Welcome to the last day of tax-loss selling ...

His/its comments will age like milk...the amount of accounts he made just to troll is ridiculous.

davgro wrote:
Duster340 wrote: looks like you are the only one buying. i am sure the low 40's will come around again, i am waiting for the announcement of the start date for P2 before i buy. my guess P2 will start last week of june. so plenty of time to get in. Q3 is in febuary maybe they will let us no the start date by then?

Low 40s again.....NOT !!

Nice buy Mugsy at C.44 even if it was just to average down. My purchase of 20K shares recently at C.48 feels good. I am hoping that today's run-up in the share price is sustained and not just an artificial spike. Time will tell.

GLTA